MiddleBrook sales and marketing update

MiddleBrook launched a co-pay program for 775 mg Moxatag amoxicillin extended-release, once-daily tablets to treat pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes in patients aged ...